KDPO supports pharmaceutical companies, health startups, medical device and AI editors, and health, prevention & life insurers to structure, prove, secure and design their sensitive data environments — with priority on health data.
KDPO intervenes when data flows already exist, when obligations strengthen, when responsibilities cross. Four verbs, four moments of intervention.
unclear → visible
Frame · Qualify
fragmented → governed
Govern · Document & prove
at risk → resilient
Protect
reactive → designed with trust
Conceive · Activate
| Before | After | Description |
|---|---|---|
| Unclear | Visible | Knowing what is processed, where, with whom and why |
| Fragmented | Governed | Governance, roles, ongoing steering |
| At risk | Resilient | Data protected, incident response prepared |
| Reactive | Designed with trust | Trust embedded from the origin |
Eligibility criterion: the nature of the data, not the sector. Sensitive data, with priority on health data.
Patient programmes, clinical trials, pharmacovigilance, data/AI partnerships, digital solutions.
Patient apps, telemedicine, digital health platforms, connected devices.
SaMD, AI health solutions, CE marking, training datasets, algorithmic traceability.
Medical questionnaires, risk selection, health scoring, prevention, sick leave, claims, life underwriting with medical component.
Flows, responsibilities and priorities lack legibility.
Governance, documentation and arbitration need structuring.
Resilience must be strengthened, an incident prepared, exposure reduced.
A product, an AI component or a high-risk device must embed trust from the start.
Organisations must be able to demonstrate their control before an audit, a partnership, a fundraising, a product launch or a sensitive decision.
The number of sensitive data flows grows with every partnership, platform, integration or product.
CNIL and EDPB now expect documented, dated, enforceable evidence — not principles.
Pharma sponsors, insurers and investors require an RGPD posture before signing.
Algorithmic systems must justify their datasets, training basis and oversight loop.
Medical software and health hosting carry their own evidence chain to maintain.
Auditability, governance and traceability decide outcomes — declarations alone do not.
The recommended entry point. In 2 to 4 weeks, KDPO produces an actionable picture of the sensitive data environment: scope, risks, priorities, trajectory.
The diagnostic is not a theoretical exercise. It is a decision tool.
The deliverables are tangible, enforceable and mobilisable in an audit, a partnership, a due diligence or a sensitive decision.
Request a diagnosticThree progressive intervention phases. The diagnostic produces the reading. The control work produces the dispositif. The continuous steering maintains its governance.
See the system
Map the flows, identify risks, grey zones, missing documents and priority arbitrations.
Document, arbitrate, secure
Document, prioritise, secure, structure governance and produce the required evidence.
Sustain governance
Maintain governance, follow regulatory shifts, prepare audits, partners and sensitive decisions.
System documented, enforceable, auditable.
Credible framework for regulators, patients, partners.
Incident response capacity, continuity maintained.
Controlled framework enabling robust innovation.
For a scoping diagnostic or a question on your exposure to sensitive data regulation.
contact@kdpo.fr